Abstract
This paper reviews worldwide efforts to interdict the type 1 diabetes (T1D) disease process, during the stage of evolution of the disease prior to the time of disease onset. The goal of intervention before disease onset is to arrest immune destruction and thus prevent or delay clinical disease. In this regard, there have been several large-scale multicenter randomized controlled clinical trials designed to prevent T1D. These have tested nicotinamide, parenteral insulin, oral insulin, nasal insulin, and the elimination of cow's milk from infant feeding.
MeSH Terms
Diabetes Mellitus, Type 1/epidemiology,mortality,prevention & control
Global Health
Humans
Models, Biological
Niacinamide/therapeutic use
Randomized Controlled Trials as Topic
Survival Analysis
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Skyler Jay S
Diabetes Research Institute, Miami, Florida 33101-6960, USA. jskyler@miami.edu
Type 1 Diabetes TrialNet Study Group
References (7)
7 references, click to expand
-
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.
Diabetes Care. 2005 May;28(5):1068-76
PMID: 15855569
-
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
Lancet. 2004 Mar 20;363(9413):925-31
PMID: 15043959
-
Effects of insulin in relatives of patients with type 1 diabetes mellitus.
N Engl J Med. 2002 May 30;346(22):1685-91
PMID: 12037147
-
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
N Engl J Med. 2005 Jun 23;352(25):2598-608
PMID: 15972866
-
Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Diabetologia. 2002 Feb;45(2):217-23
PMID: 11935153
-
Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR).
Pediatr Diabetes. 2007 Jun;8(3):117-37
PMID: 17550422
-
Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).
Diabetologia. 2003 Mar;46(3):339-46
PMID: 12687331